Andrew Hillman Introduces Biotech Innovation Grant for Undergraduate Students

Biotechnology continues to advance areas like medicine, agriculture, and environmental science. The Andrew Hillman Grant for Biotech seeks to connect with students who want to contribute to these ...
Seeking Alpha

Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa

PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and ...
Business Wire

Legend Biotech Announces Submission of Supplemental Application to the U.S. FDA for Expanded Use of CARVYKTI ® (ciltacabtagene autoleucel)

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat ...
Seeking Alpha

Krystal Biotech Announces FDA Clearance of Investigational New Drug Application for KB408 for the Treatment of Type 1 Alpha-1 Antitrypsin Deficiency

PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development, and ...
Nasdaq

Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied for ...
JEC Composites

Cathay Biotech launches bio-based thermoplastic composites project for photovoltaics

This signing marks the establishment of a long-term strategic partnership between Cathay Biotech and Fuyang Investment in the application of bio-based composite materials industry. In Fuyang, Anhui ...
FierceBiotech

Soligenix's stock sinks 38% after FDA refuses to consider lymphoma therapy application

Despite phase 3 data last year that demonstrated the effectiveness of Soligenix’s cutaneous T-cell lymphoma (CTCL) treatment, the FDA has halted the biotech's approval plan in its tracks. The agency ...
Morningstar

Kelun-Biotech's New Drug Application for Its Novel Next-generation Selective RET Inhibitor A400/EP0031 Accepted for Review by the NMPA for the Treatment of RET-fusion positive ...

CHENGDU, China, Sept. 22, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new drug application (NDA) for the Company's small molecule rearranged ...
GEN

Tough Road for Biotech Patent Prosecution

Strategic Planning Essential Under Amended USPTO Rules for Continuations and Claims The USPTO in August released its new rules governing claims and continuations for patent applications. This new ...